Report Detail

Pharma & Healthcare Global (United States, European Union and China) Non Receptor Tyrosine Protein Kinase TYK2 Market Research Report 2019-2025

  • RnM3370619
  • |
  • 01 May, 2019
  • |
  • Global
  • |
  • 115 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

In 2019, the market size of Non Receptor Tyrosine Protein Kinase TYK2 is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Non Receptor Tyrosine Protein Kinase TYK2.

This report studies the global market size of Non Receptor Tyrosine Protein Kinase TYK2, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Non Receptor Tyrosine Protein Kinase TYK2 sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Array BioPharma Inc
Bristol-Myers Squibb Company
Nimbus Therapeutics LLC
Pfizer Inc
Portola Pharmaceuticals Inc
Sareum Holdings Plc
Takeda Pharmaceutical Company Ltd
Theravance Biopharma Inc

Market Segment by Product Type
ARRY-624
BMS-986165
Cerdulatinib
NDI-031232
Others

Market Segment by Application
Follicular Lymphoma
Hypersensitivity
Lupus Nephritis
Marginal Zone B-cell Lymphoma
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Non Receptor Tyrosine Protein Kinase TYK2 status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Non Receptor Tyrosine Protein Kinase TYK2 manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Non Receptor Tyrosine Protein Kinase TYK2 are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 ARRY-624
      • 1.3.3 BMS-986165
      • 1.3.4 Cerdulatinib
      • 1.3.5 NDI-031232
      • 1.3.6 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Market Share by Application (2019-2025)
      • 1.4.2 Follicular Lymphoma
      • 1.4.3 Hypersensitivity
      • 1.4.4 Lupus Nephritis
      • 1.4.5 Marginal Zone B-cell Lymphoma
      • 1.4.6 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Market Size
      • 2.1.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue 2014-2025
      • 2.1.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales 2014-2025
    • 2.2 Non Receptor Tyrosine Protein Kinase TYK2 Growth Rate by Regions
      • 2.2.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Regions 2014-2019
      • 2.2.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Non Receptor Tyrosine Protein Kinase TYK2 Sales by Manufacturers
      • 3.1.1 Non Receptor Tyrosine Protein Kinase TYK2 Sales by Manufacturers 2014-2019
      • 3.1.2 Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Manufacturers (2014-2019)
      • 3.2.2 Non Receptor Tyrosine Protein Kinase TYK2 Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Market Concentration Ratio (CR5 and HHI)
    • 3.3 Non Receptor Tyrosine Protein Kinase TYK2 Price by Manufacturers
    • 3.4 Key Manufacturers Non Receptor Tyrosine Protein Kinase TYK2 Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Non Receptor Tyrosine Protein Kinase TYK2 Market
    • 3.6 Key Manufacturers Non Receptor Tyrosine Protein Kinase TYK2 Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 ARRY-624 Sales and Revenue (2014-2019)
      • 4.1.2 BMS-986165 Sales and Revenue (2014-2019)
      • 4.1.3 Cerdulatinib Sales and Revenue (2014-2019)
      • 4.1.4 NDI-031232 Sales and Revenue (2014-2019)
      • 4.1.5 Others Sales and Revenue (2014-2019)
    • 4.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Type
    • 4.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Type
    • 4.4 Non Receptor Tyrosine Protein Kinase TYK2 Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application

    6 United States

    • 6.1 United States Non Receptor Tyrosine Protein Kinase TYK2 Breakdown Data by Company
    • 6.2 United States Non Receptor Tyrosine Protein Kinase TYK2 Breakdown Data by Type
    • 6.3 United States Non Receptor Tyrosine Protein Kinase TYK2 Breakdown Data by Application

    7 European Union

    • 7.1 European Union Non Receptor Tyrosine Protein Kinase TYK2 Breakdown Data by Company
    • 7.2 European Union Non Receptor Tyrosine Protein Kinase TYK2 Breakdown Data by Type
    • 7.3 European Union Non Receptor Tyrosine Protein Kinase TYK2 Breakdown Data by Application

    8 China

    • 8.1 China Non Receptor Tyrosine Protein Kinase TYK2 Breakdown Data by Company
    • 8.2 China Non Receptor Tyrosine Protein Kinase TYK2 Breakdown Data by Type
    • 8.3 China Non Receptor Tyrosine Protein Kinase TYK2 Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Non Receptor Tyrosine Protein Kinase TYK2 Breakdown Data by Company
    • 9.2 Rest of World Non Receptor Tyrosine Protein Kinase TYK2 Breakdown Data by Type
    • 9.3 Rest of World Non Receptor Tyrosine Protein Kinase TYK2 Breakdown Data by Application
    • 9.4 Rest of World Non Receptor Tyrosine Protein Kinase TYK2 Breakdown Data by Countries
      • 9.4.1 Rest of World Non Receptor Tyrosine Protein Kinase TYK2 Sales by Countries
      • 9.4.2 Rest of World Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Array BioPharma Inc
      • 10.1.1 Array BioPharma Inc Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Non Receptor Tyrosine Protein Kinase TYK2
      • 10.1.4 Non Receptor Tyrosine Protein Kinase TYK2 Product Introduction
      • 10.1.5 Array BioPharma Inc Recent Development
    • 10.2 Bristol-Myers Squibb Company
      • 10.2.1 Bristol-Myers Squibb Company Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Non Receptor Tyrosine Protein Kinase TYK2
      • 10.2.4 Non Receptor Tyrosine Protein Kinase TYK2 Product Introduction
      • 10.2.5 Bristol-Myers Squibb Company Recent Development
    • 10.3 Nimbus Therapeutics LLC
      • 10.3.1 Nimbus Therapeutics LLC Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Non Receptor Tyrosine Protein Kinase TYK2
      • 10.3.4 Non Receptor Tyrosine Protein Kinase TYK2 Product Introduction
      • 10.3.5 Nimbus Therapeutics LLC Recent Development
    • 10.4 Pfizer Inc
      • 10.4.1 Pfizer Inc Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Non Receptor Tyrosine Protein Kinase TYK2
      • 10.4.4 Non Receptor Tyrosine Protein Kinase TYK2 Product Introduction
      • 10.4.5 Pfizer Inc Recent Development
    • 10.5 Portola Pharmaceuticals Inc
      • 10.5.1 Portola Pharmaceuticals Inc Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Non Receptor Tyrosine Protein Kinase TYK2
      • 10.5.4 Non Receptor Tyrosine Protein Kinase TYK2 Product Introduction
      • 10.5.5 Portola Pharmaceuticals Inc Recent Development
    • 10.6 Sareum Holdings Plc
      • 10.6.1 Sareum Holdings Plc Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Non Receptor Tyrosine Protein Kinase TYK2
      • 10.6.4 Non Receptor Tyrosine Protein Kinase TYK2 Product Introduction
      • 10.6.5 Sareum Holdings Plc Recent Development
    • 10.7 Takeda Pharmaceutical Company Ltd
      • 10.7.1 Takeda Pharmaceutical Company Ltd Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Non Receptor Tyrosine Protein Kinase TYK2
      • 10.7.4 Non Receptor Tyrosine Protein Kinase TYK2 Product Introduction
      • 10.7.5 Takeda Pharmaceutical Company Ltd Recent Development
    • 10.8 Theravance Biopharma Inc
      • 10.8.1 Theravance Biopharma Inc Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Non Receptor Tyrosine Protein Kinase TYK2
      • 10.8.4 Non Receptor Tyrosine Protein Kinase TYK2 Product Introduction
      • 10.8.5 Theravance Biopharma Inc Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Non Receptor Tyrosine Protein Kinase TYK2 Sales Channels
      • 11.2.2 Non Receptor Tyrosine Protein Kinase TYK2 Distributors
    • 11.3 Non Receptor Tyrosine Protein Kinase TYK2 Customers

    12 Market Forecast

    • 12.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales and Revenue Forecast 2019-2025
    • 12.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Forecast by Type
    • 12.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Forecast by Application
    • 12.4 Non Receptor Tyrosine Protein Kinase TYK2 Forecast by Regions
      • 12.4.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:
      Get latest Market Research Reports on Non Receptor Tyrosine Protein Kinase TYK2 . Industry analysis & Market Report on Non Receptor Tyrosine Protein Kinase TYK2 is a syndicated market report, published as Global (United States, European Union and China) Non Receptor Tyrosine Protein Kinase TYK2 Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Non Receptor Tyrosine Protein Kinase TYK2 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,594.48
      3,891.72
      5,188.96
      3,024.16
      4,536.24
      6,048.32
      509,384.00
      764,076.00
      1,018,768.00
      273,880.00
      410,820.00
      547,760.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report